◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › STAA

STAAR Surgical Company (STAA) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-09-17

STAAR Surgical Company (STAA) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Lake Forest, United States with about 921 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, STAA reported $239M in revenue and ($80M) in net income.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Interactive charts & full statements → Open the STAA valuation workbench →

STAA Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$340M	$239M	$314M	$322M	$284M	$230M	$163M	$150M	$124M	$91M	$82M	$77M	$75M	$72M	$64M	$63M	$55M	$75M	$75M	$59M	$56M
Gross Profit	$259M	$182M	$240M	$253M	$223M	$179M	$118M	$112M	$92M	$64M	$58M	$53M	$49M	$50M	$44M	$42M	$35M	$42M	$40M	$29M	$26M
Gross Margin %	76.2%	76.2%	76.3%	78.4%	78.5%	77.5%	72.4%	74.5%	73.8%	70.9%	70.8%	68.4%	65.1%	69.7%	69.4%	67.5%	63.8%	55.6%	53.5%	49.3%	47.0%
Operating Income (EBIT)	$35M	($46M)	($13M)	$28M	$44M	$33M	$7M	$12M	$7M	($4M)	($13M)	($5M)	($8M)	$1M	($1M)	$3M	($3M)	($4M)	($20M)	($14M)	($14M)
Operating Margin %	10.3%	-19.2%	-4.0%	8.7%	15.4%	14.5%	4.1%	7.9%	5.3%	-4.0%	-15.3%	-6.9%	-10.7%	1.0%	-1.9%	4.4%	-4.7%	-5.0%	-27.2%	-23.8%	-24.2%
Net Income	$4M	($80M)	($20M)	$21M	$40M	$28M	$6M	$14M	$5M	($2M)	($12M)	($7M)	($8M)	$0M	($2M)	$1M	$0M	($6M)	($23M)	($16M)	($15M)
Net Margin %	1.1%	-33.6%	-6.4%	6.6%	14.0%	11.9%	3.6%	9.3%	4.0%	-2.4%	-14.7%	-8.5%	-11.2%	0.5%	-2.8%	2.1%	0.1%	-8.2%	-31.0%	-27.0%	-26.7%
EBITDA	$32M	($74M)	($2M)	$39M	$50M	$35M	$10M	$16M	$9M	$0M	($10M)	($3M)	($5M)	$3M	$2M	$5M	$0M	$0M	($17M)	($12M)	($11M)
Earnings Per Share (EPS)	$0.07	$-1.62	$-0.41	$0.43	$0.80	$0.56	$0.12	$0.30	$0.11	$-0.05	$-0.30	$-0.17	$-0.22	$0.01	$-0.05	$0.04	$0.00	$-0.19	$-0.79	$-0.57	$-0.60
Shares Outstanding (M)	52M	50M	49M	49M	49M	49M	48M	47M	45M	41M	40M	39M	38M	39M	36M	37M	35M	32M	29M	28M	25M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STAA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$94M	$94M	$58M	$95M	$44M	$43M	$49M	$89M
Gross Profit	$70M	$68M	$44M	$78M	$33M	$28M	$32M	$68M
Gross Margin %	74.6%	72.2%	75.7%	82.2%	74.0%	65.8%	64.6%	77.3%
Operating Income (EBIT)	$10M	$17M	($11M)	$18M	($30M)	($57M)	($28M)	$6M
Operating Margin %	10.8%	18.6%	-18.9%	19.5%	-67.6%	-134.8%	-57.0%	6.4%
Net Income	$8M	$5M	($18M)	$9M	($17M)	($54M)	($34M)	$10M
Net Margin %	8.6%	5.6%	-31.7%	9.4%	-37.9%	-127.3%	-69.9%	11.3%
EBITDA	$13M	$10M	($18M)	$26M	($23M)	($32M)	($28M)	$15M
Earnings Per Share (EPS)	$0.16	$0.10	$-0.37	$0.18	$-0.34	$-1.10	$-0.69	$0.20
Shares Outstanding (M)	52M	51M	50M	50M	50M	49M	49M	50M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STAA Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	($3M)	($34M)	$16M	$15M	$36M	$44M	$21M	$26M	$13M	$3M	$1M	($2M)	($8M)	$3M	$3M	$5M	($4M)	$1M	($8M)	($11M)	($9M)
Capital Expenditures (CapEx)	$3M	$6M	$23M	$18M	$18M	$14M	$8M	$10M	$2M	$1M	$3M	$2M	$4M	$3M	$2M	$1M	$0M	$1M	$1M	$1M	$1M
Free Cash Flow (FCF)	($7M)	($40M)	($8M)	($4M)	$18M	$30M	$13M	$16M	$11M	$2M	($2M)	($4M)	($12M)	$0M	$1M	$4M	($5M)	$1M	($9M)	($12M)	($9M)
FCF Margin %	-2.0%	-16.7%	-2.4%	-1.1%	6.2%	13.2%	7.7%	10.4%	8.5%	2.0%	-2.6%	-5.5%	-16.0%	-0.1%	1.4%	7.0%	-8.6%	1.1%	-12.4%	-20.0%	-16.8%
Dividends Paid	—	—	—	$0M	—	—	—	—	$5M	$4M	$4M	$0M	$0M	$0M	$0M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STAA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$20M	($22M)	($4M)	$3M	($27M)	($6M)	$1M	$4M
Capital Expenditures (CapEx)	$0M	$0M	$2M	$1M	$2M	$1M	$6M	$6M
Free Cash Flow (FCF)	$19M	($22M)	($6M)	$2M	($29M)	($7M)	($5M)	($2M)
FCF Margin %	20.5%	-23.7%	-9.7%	1.9%	-65.5%	-16.9%	-10.4%	-2.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STAA Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$475M	$462M	$510M	$489M	$419M	$346M	$257M	$208M	$167M	$68M	$65M	$63M	$59M	$62M	$55M	$49M	$41M	$59M	$53M	$54M	$48M
Cash & Cash Equivalents	$149M	$153M	$144M	$183M	$86M	$200M	$152M	$120M	$104M	$19M	$14M	$13M	$13M	$23M	$22M	$17M	$9M	$6M	$5M	$11M	$8M
Total Liabilities	$110M	$117M	$112M	$103M	$83M	$87M	$60M	$48M	$35M	$25M	$28M	$24M	$22M	$23M	$23M	$20M	$18M	$38M	$37M	$18M	$16M
Total Debt (Short + Long-Term)	$6M	$6M	$4M	$4M	$4M	$3M	$4M	$5M	$5M	$6M	$7M	$5M	$5M	$5M	$7M	$4M	$4M	$9M	$9M	$6M	$3M
Total Shareholders' Equity	$365M	$344M	$397M	$386M	$336M	$259M	$197M	$160M	$132M	$43M	$38M	$39M	$37M	$39M	$32M	$29M	$22M	$21M	$16M	$36M	$32M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STAA viewer.

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

LMAT · LeMaitre Vascular Inc — $2 billion
BLFS · BioLife Solutions Inc — $2 billion
AZTA · Azenta Inc — $1 billion
KMTS · Kestra Medical Technologies, Ltd. Common Stock — $1 billion
MDLN · Medline Inc. Class A Common Stock — $43 billion
ALC · Alcon AG — $31 billion
AVTR · Avantor Inc — $10 billion
RGEN · Repligen Corporation — $10 billion

← STA All “S” companies STAG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.